However, Arjmand et al. reported that omentin levels were higher in cancer patients with BMI ≥ 25 and suggested that omentin may play a role in the development of obesity-related cancer in a systematic analysis evaluating omentin-1 levels, contrary to popular opinion [26]. This evidence concerns the gene ITLN1 and cancer.